[Comment] First immunogenicity and safety data on live chikungunya vaccine in an endemic area

Di |2024-09-05T00:30:01+02:00Settembre 5th, 2024|Categorie: Coronavirus Lancet|

Chikungunya virus causes an emerging mosquito-borne viral infection that is endemic to much of Latin America, Africa, and south and southeast Asia. Chikungunya is prone to 8–15 year cycles of temporary epidemic expansion, with the last global outbreak ...

[Articles] Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial

Di |2024-09-03T00:30:02+02:00Settembre 3rd, 2024|Categorie: Coronavirus Lancet|

Casirivimab and imdevimab administration before or at the time of COVID-19 vaccination reduced the elicitation of SARS-CoV-2 neutralising antibodies, but minimal effect was observed when vaccination occurred before mAb administration. Although the clin...

[Articles] Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial

Di |2024-09-03T00:30:02+02:00Settembre 3rd, 2024|Categorie: Coronavirus Lancet|

Casirivimab and imdevimab administration before or at the time of COVID-19 vaccination reduced the elicitation of SARS-CoV-2 neutralising antibodies, but minimal effect was observed when vaccination occurred before mAb administration. Although the clin...

[Correspondence] Limitations of mpox lateral flow tests in assessing orthopoxvirus immunity

Di |2024-09-03T00:30:01+02:00Settembre 3rd, 2024|Categorie: Coronavirus Lancet|

Monkeypox virus (MPXV) is a zoonotic virus and the causative agent of mpox (formerly known as monkeypox) disease1 previously limited to countries, such as Nigeria and the Democratic Republic of the Congo, except for occasional importations globally. Ho...

[Correspondence] Limitations of mpox lateral flow tests in assessing orthopoxvirus immunity

Di |2024-09-03T00:30:01+02:00Settembre 3rd, 2024|Categorie: Coronavirus Lancet|

Monkeypox virus (MPXV) is a zoonotic virus and the causative agent of mpox (formerly known as monkeypox) disease1 previously limited to countries, such as Nigeria and the Democratic Republic of the Congo, except for occasional importations globally. Ho...

[Corrections] Correction to Lancet Infect Dis 2024; published online Aug 12. https://doi.org/10.1016/S1473-3099(24)00357-8

Di |2024-08-28T00:30:01+02:00Agosto 28th, 2024|Categorie: Coronavirus Lancet|

McMahon R, Toepfer S, Sattler N, et al. Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: a single-arm, multicentre, phase 3b study. Lancet Infect Dis 202...

[Correspondence] Oropouche fever: reports of vertical transmission and deaths in Brazil

Di |2024-08-23T00:30:01+02:00Agosto 23rd, 2024|Categorie: Coronavirus Lancet|

Brazil has seen an alarming increase in cases of Oropouche fever, an emerging arboviral disease caused by the Oropouche virus, which has sparked public health concerns due to the first confirmed reports of deaths and vertical transmission. This situati...

Torna in cima